Who is affected by this change?

This affects Independence Blue Cross Oncology, Hematology providers on Commercial plans.

When does this change take effect?

This change is effective Jul 1, 2025.

Back to dashboard

CommercialCoverageMedium impact

11.07.01ab, Hematopoietic Stem Cell Transplantation (Bone Marrow Transplant)

Independence Blue Cross·Oncology, Hematology·Medical Policy

Effective date

Jul 1, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

This is a policy update for Hematopoietic Stem Cell Transplantation (Bone Marrow Transplant) procedures for commercial insurance plans. The policy has been updated with new coverage criteria or procedural requirements effective July 1, 2025.

Action Required

Action needed

By July 1, 2025: Billing team must review the full policy details at the provided URL to understand specific changes to bone marrow transplant coverage criteria. Update prior authorization procedures and documentation requirements for hematopoietic stem cell transplantation cases. Coordinate with oncology and hematology providers to ensure compliance with new policy requirements.

Related policy hubs

Independence Blue Cross policies Oncology Hematology